Indications for TURP
TURP (transurethral resection of the prostate) is indicated for men with moderate-to-severe lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction who have a prostate size of 30-80 ml. 1
Primary Clinical Indications
According to the 2023 European Association of Urology guidelines, TURP should be offered as a strong recommendation for:
Symptom-Based Indications
- Moderate-to-severe LUTS that have failed medical management (α-blockers, 5α-reductase inhibitors)
- Prostate volume specifically between 30-80 ml 1
- Patients seeking definitive surgical treatment with proven long-term durability (22-year follow-up data available) 1
Absolute Indications (Complications of Obstruction)
Based on historical practice patterns and clinical outcomes, TURP is indicated for:
- Acute urinary retention - particularly when medical management fails or after failed trial without catheter 2, 3
- Chronic urinary retention with renal impairment
- Recurrent urinary tract infections attributable to prostatic obstruction
- Bladder stones or diverticula secondary to obstruction
- Recurrent gross hematuria from prostatic bleeding
- Significant post-void residual urine causing complications 2
Prostate Size Considerations
The guidelines provide clear size-based algorithms:
- <30 ml: Offer transurethral incision of the prostate (TUIP) instead, provided there is no middle lobe 1
- 30-80 ml: TURP is the primary recommendation (strong evidence) 1
- >80 ml: Consider enucleation techniques (HoLEP, bipolar enucleation) or open prostatectomy rather than TURP 1
Important Clinical Nuances
Patient Selection Pitfalls
Common mistake: Operating on patients with bladder dysfunction rather than true obstruction. The evidence shows increasing rates of long-term catheterization needs (2% to 11.5%) in modern series, likely reflecting delayed presentation after prolonged medical therapy 3. Consider urodynamic studies before surgery, especially in:
- Patients with acute urinary retention (higher risk of postoperative complications) 2
- Those with chronic retention (may have irreversible bladder dysfunction)
- Younger patients where alternative procedures should be strongly considered 4
Anticoagulation Considerations
TURP can be performed in patients on anticoagulation or antiplatelet therapy, though this leads to longer catheterization times, higher transfusion rates, and increased re-hospitalization 1. Alternative laser techniques may be preferable in this population.
Mortality and Morbidity
Modern TURP has excellent safety: perioperative mortality is 0.1% and morbidity 11.1% 1. Bipolar TURP demonstrates a more favorable perioperative safety profile compared to monopolar TURP while maintaining equivalent efficacy 1.
Sexual Function Impact
Retrograde ejaculation occurs in approximately 50-57% of patients 1. Erectile function measured by IIEF-5 remains similar to baseline at 12 months 1. Patients prioritizing ejaculatory preservation should be counseled about alternatives like prostatic urethral lift.
Contraindications to Consider
While not explicitly stated in guidelines, avoid TURP when:
- Prostate size <30 ml without middle lobe (use TUIP instead)
- Prostate size >80 ml (consider enucleation or open surgery)
- Primary bladder dysfunction rather than obstruction
- Patient desires ejaculatory preservation with prostate <70 ml (consider prostatic urethral lift) 1